| Ms Patricia Ann Parrish, PA-C | |
|
1322 Locust Ave, Fairmont, WV 26554-1436 | |
| (304) 366-0700 | |
| (304) 367-8766 |
| Full Name | Ms Patricia Ann Parrish |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 1322 Locust Ave, Fairmont, West Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699714014 | NPI | - | NPPES |
| 004708700 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 793 (West Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Patricia Ann Parrish, PA-C Po Box 1112, Fairmont, WV 26555-1112 Ph: (304) 366-0700 | Ms Patricia Ann Parrish, PA-C 1322 Locust Ave, Fairmont, WV 26554-1436 Ph: (304) 366-0700 |
News Archive
Protherics PLC today announced the initiation of a phase 2a proof-of-concept study of Prolarix, a targeted prodrug chemotherapy being developed for the treaent of primary liver cancer (hepatocellular carcinoma or "HCC"). This follows promising data from a phase 1 study of Prolarix, presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, USA on 2 June 2008.
First lady Michelle Obama and French first lady Carla Bruni-Sarkozy on Friday in Strasbourg, France, agreed to collaborate on efforts to address HIV/AIDS worldwide, AFP/Google.com reports.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that ARX-04 (sufentanil sublingual tablet, 30 mcg) met primary and secondary endpoints in a multi-center, double-blind, placebo-controlled Phase 3 trial (SAP301) designed to study the short-term treatment of patients with moderate-to-severe acute pain following ambulatory abdominal surgery.
Abraxis BioScience, Inc., a fully integrated, global biotechnology company, today announced that Taiho Pharmaceutical Co., Ltd. has received approval from the Ministry of Health, Labor and Welfare to market ABRAXANE IV Infusion 100 mg, Paclitaxel Injection (Suspension with Albumin), for use in the treatment of breast cancer. The New Drug Application (J-NDA) for ABRAXANE was filed with the Ministry of Health, Labor and Welfare in 2008.
NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced the commercial launch of the nCounter® RNA:Protein PanCancer Immune Profiling Panel
› Verified 9 days ago
Ms. Rubina K Dasilva, PAC Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1322 Locust Ave, Fairmont, WV 26554 Phone: 304-366-0700 Fax: 304-366-9529 | |
Ann Louise Nicely, PHYSICIAN ASSISTANT Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 60 Roxbury Rd, Whitehall Medical, Pllc, Fairmont, WV 26554 Phone: 304-363-6600 Fax: 304-363-7700 | |
Christina Michelle Manchin, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 181 Middletown Cir, Fairmont, WV 26554 Phone: 304-367-1970 Fax: 304-367-1980 | |
Mr. Nicholas C Vance, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1325 Locust Ave, Fairmont, WV 26554 Phone: 304-367-7100 | |
Tayla Jo Anderson, Physician Assistant Medicare: Medicare Enrolled Practice Location: 1325 Locust Ave Ste 4b, Fairmont, WV 26554 Phone: 304-974-3297 Fax: 304-974-3299 | |
Amanda Marie Skrinjorich, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1325 Locust Ave, Fairmont, WV 26554 Phone: 304-367-7100 | |
Amy Gruber, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1325 Locust Ave, Fairmont, WV 26554 Phone: 304-367-7541 |